Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 887.03M | 908.29M | 975.82M | 899.92M | 770.46M | 648.01M |
Gross Profit | 187.19M | 189.25M | 202.10M | 174.93M | 166.86M | 154.20M |
EBITDA | 25.18M | -381.00K | 45.06M | 30.25M | 50.18M | 27.68M |
Net Income | -17.59M | -16.52M | -5.18M | -14.06M | 3.41M | -7.95M |
Balance Sheet | ||||||
Total Assets | 670.74M | 621.56M | 679.90M | 652.11M | 665.40M | 621.41M |
Cash, Cash Equivalents and Short-Term Investments | 35.16M | 71.83M | 40.84M | 54.80M | 85.55M | 73.92M |
Total Debt | 178.89M | 208.06M | 203.01M | 179.85M | 184.12M | 159.11M |
Total Liabilities | 394.50M | 376.30M | 392.18M | 371.16M | 369.45M | 324.77M |
Stockholders Equity | 276.24M | 245.26M | 287.72M | 280.94M | 295.95M | 296.63M |
Cash Flow | ||||||
Free Cash Flow | 24.96M | 23.45M | -33.55M | -24.80M | -63.28M | -3.82M |
Operating Cash Flow | 49.54M | 47.75M | 4.95M | 6.81M | -36.25M | 28.64M |
Investing Cash Flow | -24.74M | -24.47M | -36.98M | -28.58M | 28.04M | -33.88M |
Financing Cash Flow | 4.95M | 11.12M | 17.48M | -7.30M | 22.88M | 6.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $291.68M | 14.14 | 9.91% | ― | 5.54% | 398.82% | |
65 Neutral | $240.81M | ― | -7.17% | ― | 5.53% | 60.54% | |
64 Neutral | kr11.54B | 16.57 | 10.84% | 9.89% | 2.66% | 5.01% | |
60 Neutral | $126.11M | 4.38 | 8.05% | ― | 18.33% | -26.25% | |
60 Neutral | $126.11M | 4.38 | 8.05% | ― | 18.33% | -26.25% | |
58 Neutral | $221.93M | ― | -6.63% | ― | -8.90% | -346.80% | |
52 Neutral | $68.58M | 1.82 | -26.02% | ― | -23.78% | -179.48% | |
41 Neutral | $4.57M | ― | -80.07% | ― | -3.63% | 36.19% |
Stoneridge held its Annual Meeting of Shareholders on May 13, 2025, where shareholders approved the 2025 Long-Term Incentive Plan, authorizing 726,000 common shares for eligible participants. Additionally, seven nominees were elected to the Board of Directors for one-year terms, Ernst & Young LLP was ratified as the independent public accounting firm for 2025, and a non-binding advisory resolution on 2024 executive compensation was approved.
The most recent analyst rating on (SRI) stock is a Buy with a $27.50 price target. To see the full list of analyst forecasts on Stoneridge stock, see the SRI Stock Forecast page.
Stoneridge reported its financial results for the first quarter of 2025, with sales of $217.9 million and a net loss of $7.2 million. The company achieved record sales for its MirrorEye and SMART 2 products, despite challenges in production volumes in certain markets. The company maintained its full-year 2025 guidance, highlighting improvements in operating margins and cash flow management. Stoneridge continues to address tariff impacts and supply chain complexities, ensuring compliance with financial leverage ratios.